CASEID,PRIMARYID,CASEVERSION,I_F_CODE,EVENT_DT,MFR_DT,INIT_FDA_DT,FDA_DT,REPT_COD,AUTH_NUM,MFR_NUM,MFR_SNDR,LIT_REF,AGE,AGE_COD,AGE_GRP,SEX,E_SUB,WT,WT_COD,REPT_DT,TO_MFR,OCCP_COD,REPORTER_COUNTRY,OCCR_COUNTRY,DRUGNAME,PT,PRIMARYID_OUTC,OUTC_COD,PRIMARYID_RPSR,RPSR_COD,PRIMARYID_THER,DSG_DRUG_SEQ,START_DT,END_DT,DUR,DUR_COD,PRIMARYID_INDI,INDI_DRUG_SEQ,INDI_PT
11991033,1199103322,22,F,,20240927,20160202,20241010,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-004939,BRISTOL MYERS SQUIBB,Literature citation unavailable,54,YR,A,M,Y,,,20241010,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Loss of personal independence in daily activities;Off label use;Paranoia;Prescribed overdose;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,1199103322,HO,,,,,,,,,1199103322,1,HIV infection
13906408,1390640862,62,F,,20241029,20170825,20241104,EXP,,CA-009507513-0809CAN00001,MERCK,"Harris M, Larsen G, Montaner JSG. Exacerbation of depression associated with starting raltegravir: a report of four cases.. AIDS. 2008;22(14):1890-2",54,YR,,M,Y,,,20241104,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Diplopia;Drug interaction;Eyelid ptosis;Incorrect route of product administration;Intentional product use issue;Lipodystrophy acquired;Loss of personal independence in daily activities;Mitochondrial toxicity;Off label use;Paranoia;Prescribed overdose;Product use in unapproved indication;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,1390640862,HO,,,1390640862,1,20070620,,,,1390640862,1,HIV infection
14527089,145270898,8,F,,20241210,20180213,20241224,EXP,,IE-MYLANLABS-2018M1009569,AUROBINDO,"Broderick C, Quinlan C, Gulmann C, O^Kane M.. Recalcitrant Cutaneous Sarcoidosis, With Response to Daylight Photodynamic Therapy.. Autumn Meeting of the Irish Association of Dermatologists. 2016",37,YR,,F,Y,,,20241224,,HP,IE,IE,EFAVIRENZ,Cushingoid;Drug ineffective for unapproved indication;Leukopenia;Off label use;Product use in unapproved indication;Skin atrophy,145270898,OT,,,,,,,,,145270898,1,Sarcoidosis
14604016,146040165,5,F,,20241212,20180306,20241217,PER,IE-GLAXOSMITHKLINE-IE2018GSK008052,IE-LEO Pharma-307607,LEO PHARM,"Broderick C, Quinlan C, Gulmann C, O^Kane M, Recalcitrant cutaneous sarcoidosis, with response to daylight photodynamic therapy, J AM ACAD DERMATOL; Jun-2017.",37,YR,,F,Y,,,20241217,,HP,IE,IE,EFAVIRENZ,Cushingoid;Drug ineffective for unapproved indication;Leukopenia;Off label use;Product use in unapproved indication;Skin atrophy,146040165,OT,,,,,,,,,146040165,1,Sarcoidosis
14689574,146895747,7,F,,20241210,20180328,20241223,EXP,,IE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-007426,BRISTOL-MYERS SQUIBB COMPANY,"Broderick C, Quinlan C, Gulmann C, O^kane M. Recalcitrant cutaneous sarcoidosis, with response to daylight photodynamic therapy. Autumn Meeting of the Irish Association of Dermatologists. 2016 Oct;45.",37,YR,A,F,Y,,,20241223,,HP,IE,IE,EFAVIRENZ,Cushingoid;Drug ineffective;Leukopenia;Off label use;Skin atrophy,146895747,OT,,,,,,,,,146895747,1,Sarcoidosis
15626751,1562675143,43,F,,20241113,20181116,20241120,EXP,,CA-ABBVIE-18S-028-2552613-00,ABBVIE,,54,YR,,M,Y,,,20241120,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities;Paranoia;Prescribed overdose;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,1562675143,DE,,,,,,,,,1562675143,1,Bipolar disorder
16350708,163507085,5,F,20150301,20241112,20190524,20241114,EXP,,US-GILEAD-2019-0409332,GILEAD,,44,YR,A,M,Y,,,20241114,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Chronic kidney disease;Economic problem;Emotional distress;Multiple fractures;Osteonecrosis;Osteoporosis;Pain;Renal failure;Renal injury;Spinal fracture,163507085,HO,,,163507085,1,2009,2011,,,163507085,1,HIV infection
16623707,166237078,8,F,20120615,20240930,20190724,20241003,EXP,,US-GILEAD-2019-0419555,GILEAD,,56,YR,A,M,Y,57.2,KG,20241003,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Back pain;Chronic kidney disease;Condition aggravated;Economic problem;Emotional distress;Glomerulonephritis;Haematuria;Intervertebral disc degeneration;Neck pain;Nephropathy;Orthostatic hypotension;Osteoarthritis;Osteopenia;Pain;Pain in extremity;Proteinuria;Renal cyst;Renal failure;Scoliosis;Spinal disorder;Spinal pain,166237078,OT,,,166237078,1,2006,2018,2188,DAY,166237078,1,HIV infection
16912943,169129434,4,F,,20240924,20191014,20241004,EXP,,CA-TEVA-2019-CA-1118733,TEVA,,54,YR,,M,Y,,,20241004,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,169129434,HO,,,,,,,,,169129434,1,Mental disorder
17743771,177437716,6,F,,20241204,20200505,20241211,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2020GSK075602,VIIV,,,,,,Y,,,20241211,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose;Product use in unapproved indication,177437716,OT,,,,,,,,,177437716,1,HIV infection
17743782,177437826,6,F,,20241204,20200505,20241211,EXP,,CA-GLAXOSMITHKLINE-CA2020GSK075602,GLAXOSMITHKLINE,,,,,,Y,,,20241211,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose;Product use in unapproved indication,177437826,DE,,,,,,,,,177437826,1,HIV infection
17943142,179431425,5,F,20111229,20241015,20200625,20241022,EXP,,US-GILEAD-2020-0474690,GILEAD,,51,YR,A,M,Y,64.41,KG,20241022,,LW,US,US,EFAVIRENZ;SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone density decreased;Bone loss;Emotional distress;Multiple fractures;Osteonecrosis;Osteopenia;Pain;Renal injury;Skeletal injury;Spinal compression fracture,179431425,OT,,,179431425,1,2007,2019,,,179431425,1,HIV infection
18179409,1817940910,10,F,,20241022,20200821,20241028,EXP,,CA-ROCHE-2583896,ROCHE,,52,YR,A,M,Y,,,20241028,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Blood lactic acid increased;Diplopia;Dysphagia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia;Progressive external ophthalmoplegia,1817940910,OT,,,,,,,,,1817940910,1,HIV infection
18194619,181946199,9,F,,20240919,20200825,20241023,EXP,,CA-AstraZeneca-2020SF06767,ALEXION PHARMACEUTICALS,,54,YR,A,,Y,,,20241023,,,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Off label use;Prescribed overdose;Product use in unapproved indication,181946199,DE,,,,,,,,,181946199,1,Product used for unknown indication
18399149,183991494,4,F,20200921,20241107,20201019,20241119,EXP,,JP-NOVOPROD-759390,NOVO NORDISK,,41,YR,,M,Y,42,KG,20241120,,MD,JP,JP,EFAVIRENZ,Anaphylactic reaction;Hypersensitivity,183991494,OT,,,183991494,1,20150601,20201005,2,DAY,183991494,1,Factor VIII deficiency
18495438,184954383,3,F,,20240919,20201112,20241109,EXP,,CA-AstraZeneca-2020SF45204,ALEXION PHARMACEUTICALS,,54,YR,A,,Y,,,20241109,,,CA,CA,EFAVIRENZ,Depression;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose;Product use in unapproved indication,184954383,DE,,,,,,,,,184954383,1,Bipolar disorder
18888480,188884803,3,F,,20240927,20210212,20241007,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013018,BRISTOL MYERS SQUIBB,,54,YR,A,M,Y,,,20241007,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities;Off label use,188884803,DE,,,,,,,,,188884803,1,HIV infection
19557924,195579244,4,F,20101201,20241015,20210714,20241022,EXP,,US-GILEAD-2021-0539887,GILEAD,,49,YR,A,M,Y,120.18,KG,20241022,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Bone density abnormal;Bone density decreased;Chronic kidney disease;Emotional distress;Gait disturbance;Pain;Tooth loss,195579244,OT,,,195579244,1,19980101,20201231,8400,DAY,195579244,1,HIV infection
19938893,1993889325,25,F,,20241108,20211011,20241115,EXP,,CA-MYLANLABS-11P-028-0710272-00,MYLAN,,54,YR,,M,Y,,,20241115,,CN,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Lymphoproliferative disorder;Paranoia;Prescribed overdose;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,1993889325,DS,,,1993889325,129,,,4,YR,1993889325,1,Bipolar disorder
20858432,2085843210,10,F,,20241029,20220521,20241031,EXP,,CA-009507513-2205CAN005476,MERCK,,54,YR,,M,Y,,,20241031,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,2085843210,HO,,,,,,,,,2085843210,1,HIV infection
20895023,208950238,8,F,20100629,20220721,20220531,20241210,EXP,GB-EMA-DD-20180827-Ashwinihvp-120514,GB-GLAXOSMITHKLINE-GB2022083878,GLAXOSMITHKLINE,,,,,,Y,,,20241210,,MD,GB,GB,EFAVIRENZ,Abortion spontaneous;Alanine aminotransferase increased;Aspartate aminotransferase increased;Caesarean section;Exposure during pregnancy;Hepatic cytolysis;Intentional product use issue;Ultrasound antenatal screen,208950238,CA,,,208950238,1,20090101,20100110,374,DAY,208950238,1,Antiretroviral therapy
20895036,208950368,8,F,20100629,20220721,20220531,20241210,EXP,GB-EMA-DD-20180827-Ashwinihvp-120514,GB-VIIV HEALTHCARE LIMITED-GB2022083878,VIIV,,,,,,Y,,,20241210,,MD,GB,GB,EFAVIRENZ,Abortion spontaneous;Alanine aminotransferase increased;Aspartate aminotransferase increased;Caesarean section;Exposure during pregnancy;Hepatic cytolysis;Intentional product use issue;Ultrasound antenatal screen,208950368,HO,,,208950368,1,20090101,20100110,374,DAY,208950368,1,Antiretroviral therapy
20993425,209934259,9,F,,20241104,20220622,20241109,EXP,,CA-JNJFOC-20220629261,JOHNSON AND JOHNSON,,54,YR,A,M,Y,,,20241109,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,209934259,HO,,,,,,,,,209934259,1,Depression
21022167,210221676,6,F,20171006,20221215,20220629,20241210,EXP,GB-EMA-DD-20180827-KSEVHUMANWT-125137,GB-VIIV HEALTHCARE LIMITED-GB2022098218,VIIV,,,,,,Y,,,20241210,,MD,GB,GB,EFAVIRENZ,Cleft lip and palate;Foetal exposure during pregnancy;Hydrops foetalis;Trisomy 18;Ultrasound antenatal screen,210221676,HO,,,210221676,1,20090101,20100610,525,DAY,210221676,1,Product used for unknown indication
21022189,210221896,6,F,20171006,20221215,20220629,20241210,EXP,GB-EMA-DD-20180827-KSEVHUMANWT-125137,GB-GLAXOSMITHKLINE-GB2022098218,GLAXOSMITHKLINE,,,,,,Y,,,20241210,,MD,GB,GB,EFAVIRENZ,Cleft lip and palate;Foetal exposure during pregnancy;Hydrops foetalis;Trisomy 18;Ultrasound antenatal screen,210221896,CA,,,210221896,1,20090101,20100610,525,DAY,210221896,1,Product used for unknown indication
21411803,2141180310,10,F,,20240923,20221005,20241002,EXP,,CA-MYLANLABS-2022M1110802,MYLAN,,54,YR,,M,Y,,,20241002,,HP,CA,CA,EFAVIRENZ,Anxiety;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,2141180310,OT,,,2141180310,1,2007,,,,2141180310,1,Bipolar disorder
21583026,215830265,5,F,,20240927,20221111,20241009,EXP,CA-MHPD-E2B_05617673,CA-Accord-284705,ACCORD,,54,YR,A,M,Y,,,20241009,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,215830265,OT,,,,,,,,,215830265,1,Depression
21923583,219235833,3,F,,20240927,20230130,20241007,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2023-013331,BRISTOL MYERS SQUIBB,,54,YR,A,M,Y,,,20241007,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Death,219235833,DE,,,,,,,,,219235833,1,HIV infection
22183781,221837814,4,F,20131023,20241004,20230406,20241009,PER,,US-GILEAD-2023-0622978,GILEAD,,48,YR,A,F,Y,76.19,KG,20241009,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Bone demineralisation;Chronic kidney disease;Depression;Emotional distress;Osteoporosis;Pain;Renal failure;Renal impairment,221837814,HO,,,221837814,1,2005,200608,,,221837814,1,HIV infection
22672016,226720162,2,F,,20240919,20230705,20241014,EXP,,CA-AstraZeneca-2023A151283,ALEXION PHARMACEUTICALS,,54,YR,A,,Y,,,20241014,,,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,226720162,HO,,,,,,,,,226720162,1,Depression
22672219,226722192,2,F,,20240927,20230705,20241008,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2023-092636,BRISTOL MYERS SQUIBB,,54,YR,A,M,Y,,,20241008,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Hospitalisation;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,226722192,HO,,,,,,,,,226722192,1,HIV infection
22947709,229477092,2,F,,20241118,20230915,20241122,EXP,,CA-MYLANLABS-2023M1092612,MYLAN,,54,YR,,M,Y,,,20241122,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,229477092,HO,,,,,,,,,229477092,1,Bipolar disorder
23131537,231315377,7,F,20231001,20240702,20231031,20241127,EXP,,US-THERATECHNOLOGIES INC.-2023-THE-IBA-000432,Unknown Manufacturer,,,,,,Y,,,20241127,,CN,US,US,SUSTIVA,Abdominal pain upper;Decreased appetite;Depression;Fatigue;Hypoaesthesia;Paraesthesia;Scar,,,,,231315377,1,202310,202310,,,231315377,1,HIV infection
23535335,235353353,3,F,,20241115,20240218,20241128,EXP,,PT-AUROBINDO-AUR-APL-2024-007326,AUROBINDO,"Mariana Dias Pais, Fernando Godinho Pereira, Helena Pires, Ana Messias, Cristina Santos. FROM SUSCEPTIBILITY TO INSULT, A CASE OF ACUTE INTERSTITIAL NEPHRITIS. Portuguese Journal of Nephrology and Hypertension. Abstract No. 104",58,YR,,M,Y,,,20241128,,MD,PT,PT,EFAVIRENZ,Anaemia macrocytic;Fanconi syndrome;Renal tubular injury;Tubulointerstitial nephritis,235353353,OT,,,,,,,,,235353353,1,HIV infection
23830638,238306382,2,F,20190101,20241008,20240508,20241016,EXP,,BE-MYLANLABS-2024M1039683,MYLAN,"Martin C, Moretti M, Stoffels K, Van Laethem K, Verhofstede C, Van Den Wijngaert S. The challenge of adherence to a complex antiretroviral therapy regimen in an individual with multidrug-resistant HIV. Topics in Antiviral Medicine. 2024;32 (2):437-444",35,YR,,F,Y,,,20241016,,MD,BE,BE,EFAVIRENZ,Acute kidney injury;Cachexia;Depression;Drug intolerance;Gene mutation;Multiple-drug resistance;Mycobacterium avium complex infection;Myocarditis;Pneumocystis jirovecii pneumonia;Progressive multifocal leukoencephalopathy;Virologic failure,238306382,OT,,,238306382,4,2009,,,,238306382,1,HIV infection
24327264,243272642,2,F,,20240912,20240917,20241231,EXP,,ZA-AstraZeneca-2024A209698,ALEXION PHARMACEUTICALS,,52,YR,A,,Y,,,20241231,,,ZA,ZA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR\TENOFOVIR DISOPROXIL FUMARATE,Stress,243272642,HO,,,,,,,,,243272642,2,Diabetes mellitus
24385756,243857561,1,I,,20240919,20241001,20241001,EXP,,CA-ASTRAZENECA-202409CAN004386CA,ALEXION PHARMACEUTICALS,,,,,,Y,,,20241001,,,CA,CA,SUSTIVA,Depression;Drug interaction,243857561,DE,,,,,,,,,243857561,1,Product used for unknown indication
24385854,243858541,1,I,,20240919,20241001,20241001,EXP,,CA-ASTRAZENECA-202409CAN004695CA,ALEXION PHARMACEUTICALS,,54,YR,A,,Y,,,20241001,,,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,243858541,OT,,,,,,,,,243858541,1,Bipolar disorder
24386863,243868631,1,I,,20240930,20241002,20241002,EXP,,ZA-GILEAD-2024-0689521,GILEAD,"Moseki R, Barber D, Du BE, Shey M., Van DP, Wilkinson R, et al.. Phenotypic Profile of Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses in People with Advanced Human Immunodeficiency Virus Who Develop  Tuberculosis-Associated Immune Reconstitution  Inflammatory Syndrome. Open Forum Infectious Diseases. 2023;10(1):UNK. doi:10.1093/ofid/ofac546",,,A,,Y,,,20241002,,HP,ZA,ZA,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,243868631,OT,,,,,,,,,243868631,1,HIV infection
24386872,243868721,1,I,,20240930,20241002,20241002,EXP,,ZA-GILEAD-2024-0689478,GILEAD,"Moseki R, Barber D, Du BE, Shey M., Van DP, Wilkinson R, et al.. Phenotypic Profile of Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses in People with Advanced Human Immunodeficiency Virus Who Develop  Tuberculosis-Associated Immune Reconstitution  Inflammatory Syndrome. Open Forum Infectious Diseases. 2023;10(1):UNK. doi:10.1093/ofid/ofac546",,,A,,Y,,,20241002,,HP,ZA,ZA,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,243868721,OT,,,,,,,,,243868721,1,HIV infection
24387341,243873411,1,I,,20240930,20241002,20241002,EXP,,ZA-GILEAD-2024-0689511,GILEAD,"Moseki R, Barber D, Du BE, Shey M., Van DP, Wilkinson R, et al.. Phenotypic Profile of Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses in People with Advanced Human Immunodeficiency Virus Who Develop  Tuberculosis-Associated Immune Reconstitution  Inflammatory Syndrome. Open Forum Infectious Diseases. 2023;10(1):UNK. doi:10.1093/ofid/ofac546",,,A,,Y,,,20241002,,HP,ZA,ZA,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,243873411,OT,,,,,,,,,243873411,1,HIV infection
24387344,243873441,1,I,,20240930,20241002,20241002,EXP,,ZA-GILEAD-2024-0689509,GILEAD,"Moseki R, Barber D, Du BE, Shey M., Van DP, Wilkinson R, et al.. Phenotypic Profile of Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses in People with Advanced Human Immunodeficiency Virus Who Develop  Tuberculosis-Associated Immune Reconstitution  Inflammatory Syndrome. Open Forum Infectious Diseases. 2023;10(1):UNK. doi:10.1093/ofid/ofac546",,,A,,Y,,,20241002,,HP,ZA,ZA,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,243873441,OT,,,,,,,,,243873441,1,HIV infection
24387447,243874471,1,I,,20240930,20241002,20241002,EXP,,ZA-GILEAD-2024-0689513,GILEAD,"Moseki R, Barber D, Du BE, Shey M., Van DP, Wilkinson R, et al.. Phenotypic Profile of Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses in People with Advanced Human Immunodeficiency Virus Who Develop  Tuberculosis-Associated Immune Reconstitution  Inflammatory Syndrome. Open Forum Infectious Diseases. 2023;10(1):UNK. doi:10.1093/ofid/ofac546",,,A,,Y,,,20241002,,HP,ZA,ZA,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,243874471,OT,,,,,,,,,243874471,1,HIV infection
24387464,243874641,1,I,,20240930,20241002,20241002,EXP,,ZA-GILEAD-2024-0689517,GILEAD,"Moseki R, Barber D, Du BE, Shey M., Van DP, Wilkinson R, et al.. Phenotypic Profile of Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses in People with Advanced Human Immunodeficiency Virus Who Develop  Tuberculosis-Associated Immune Reconstitution  Inflammatory Syndrome. Open Forum Infectious Diseases. 2023;10(1):UNK. doi:10.1093/ofid/ofac546",,,A,,Y,,,20241002,,HP,ZA,ZA,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,243874641,OT,,,,,,,,,243874641,1,HIV infection
24387516,243875161,1,I,,20240930,20241002,20241002,EXP,,ZA-GILEAD-2024-0689508,GILEAD,"Moseki R, Barber D, Du BE, Shey M., Van DP, Wilkinson R, et al.. Phenotypic Profile of Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses in People with Advanced Human Immunodeficiency Virus Who Develop  Tuberculosis-Associated Immune Reconstitution  Inflammatory Syndrome. Open Forum Infectious Diseases. 2023;10(1):UNK. doi:10.1093/ofid/ofac546",,,A,,Y,,,20241002,,HP,ZA,ZA,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,243875161,OT,,,,,,,,,243875161,1,HIV infection
24387527,243875271,1,I,,20240930,20241002,20241002,EXP,,ZA-GILEAD-2024-0689510,GILEAD,"Moseki R, Barber D, Du BE, Shey M., Van DP, Wilkinson R, et al.. Phenotypic Profile of Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses in People with Advanced Human Immunodeficiency Virus Who Develop  Tuberculosis-Associated Immune Reconstitution  Inflammatory Syndrome. Open Forum Infectious Diseases. 2023;10(1):UNK. doi:10.1093/ofid/ofac546",,,A,,Y,,,20241002,,HP,ZA,ZA,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,243875271,OT,,,,,,,,,243875271,1,HIV infection
24387854,243878541,1,I,,20240930,20241002,20241002,EXP,,ZA-GILEAD-2024-0689516,GILEAD,"Moseki R, Barber D, Du BE, Shey M., Van DP, Wilkinson R, et al.. Phenotypic Profile of Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses in People with Advanced Human Immunodeficiency Virus Who Develop  Tuberculosis-Associated Immune Reconstitution  Inflammatory Syndrome. Open Forum Infectious Diseases. 2023;10(1):UNK. doi:10.1093/ofid/ofac546",,,A,,Y,,,20241002,,HP,ZA,ZA,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,243878541,OT,,,,,,,,,243878541,1,HIV infection
24387856,243878561,1,I,,20240930,20241002,20241002,EXP,,ZA-GILEAD-2024-0689512,GILEAD,"Moseki R, Barber D, Du BE, Shey M., Van DP, Wilkinson R, et al.. Phenotypic Profile of Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses in People with Advanced Human Immunodeficiency Virus Who Develop  Tuberculosis-Associated Immune Reconstitution  Inflammatory Syndrome. Open Forum Infectious Diseases. 2023;10(1):UNK. doi:10.1093/ofid/ofac546",,,A,,Y,,,20241002,,HP,ZA,ZA,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,243878561,OT,,,,,,,,,243878561,1,HIV infection
24388086,243880861,1,I,,20240930,20241002,20241002,EXP,,ZA-GILEAD-2024-0689520,GILEAD,"Moseki R, Barber D, Du BE, Shey M., Van DP, Wilkinson R, et al.. Phenotypic Profile of Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses in People with Advanced Human Immunodeficiency Virus Who Develop  Tuberculosis-Associated Immune Reconstitution  Inflammatory Syndrome. Open Forum Infectious Diseases. 2023;10(1):UNK. doi:10.1093/ofid/ofac546",,,A,,Y,,,20241002,,HP,ZA,ZA,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,243880861,OT,,,,,,,,,243880861,1,HIV infection
24388099,243880991,1,I,,20240930,20241002,20241002,EXP,,ZA-GILEAD-2024-0689518,GILEAD,"Moseki R, Barber D, Du BE, Shey M., Van DP, Wilkinson R, et al.. Phenotypic Profile of Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses in People with Advanced Human Immunodeficiency Virus Who Develop  Tuberculosis-Associated Immune Reconstitution  Inflammatory Syndrome. Open Forum Infectious Diseases. 2023;10(1):UNK. doi:10.1093/ofid/ofac546",,,A,,Y,,,20241002,,HP,ZA,ZA,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,243880991,OT,,,,,,,,,243880991,1,HIV infection
24390277,243902771,1,I,,20240925,20241003,20241003,EXP,,CA-GSK-CA2024GSK121256,GLAXOSMITHKLINE,,,,,,Y,,,20241003,,CN,CA,CA,EFAVIRENZ,Depression;Drug interaction,243902771,DE,,,,,,,,,243902771,1,Product used for unknown indication
24390748,243907481,1,I,,20240930,20241003,20241003,EXP,,ZA-GILEAD-2024-0689519,GILEAD,"Moseki R, Barber D, Du BE, Shey M., Van DP, Wilkinson R, et al.. Phenotypic Profile of Mycobacterium Tuberculosis-Specific CD4 T-Cell Responses in People with Advanced Human Immunodeficiency Virus Who Develop  Tuberculosis-Associated Immune Reconstitution  Inflammatory Syndrome. Open Forum Infectious Diseases. 2023;10(1):UNK. doi:10.1093/ofid/ofac546",,,A,,Y,,,20241003,,HP,ZA,ZA,EFAVIRENZ,Immune reconstitution inflammatory syndrome associated tuberculosis,243907481,OT,,,,,,,,,243907481,1,HIV infection
24391558,243915581,1,I,,20240923,20241003,20241003,EXP,,ZA-GILEAD-2024-0688887,GILEAD,"Bronkhorst E., Joseph-Busby M., Bezuidenhout S. Reducing medication errors in HIV-positive patients: Influence of a clinical pharmacist. Southern African Journal of HIV Medicine. 2024;25(1):a1594. doi:10.4102/sajhivmed.v25i1.1594",,,A,,Y,,,20241003,,HP,ZA,ZA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Drug-induced liver injury;Prescription drug used without a prescription,243915581,OT,,,,,,,,,243915581,1,HIV infection
24392113,243921131,1,I,,20240924,20241003,20241003,EXP,,CA-TEVA-VS-3247158,TEVA,,,,,M,Y,,,20241003,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,243921131,DE,,,,,,,,,243921131,1,Product used for unknown indication
24392114,243921141,1,I,,20240924,20241003,20241003,EXP,,CA-TEVA-VS-3247164,TEVA,,,,,M,Y,,,20241003,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,243921141,DE,,,,,,,,,243921141,1,Product used for unknown indication
24392131,243921311,1,I,,20240924,20241003,20241003,EXP,,CA-TEVA-VS-3247749,TEVA,,,,,M,Y,,,20241003,,CN,CA,CA,EFAVIRENZ,Depression;Drug interaction,243921311,DE,,,,,,,,,243921311,1,Product used for unknown indication
24392960,243929601,1,I,,20240924,20241003,20241003,EXP,,CA-TEVA-VS-3247797,TEVA,,,,,M,Y,,,20241003,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,243929601,DE,,,,,,,,,243929601,1,Product used for unknown indication
24393005,243930051,1,I,20240913,20240927,20241003,20241003,EXP,,CN-GSK-CN2024APC119543,GLAXOSMITHKLINE,,,,,,Y,,,20241003,,HP,CN,CN,EFAVIRENZ,Renal injury,243930051,HO,,,243930051,1,20171105,20240913,2504,DAY,243930051,1,HIV infection
24393006,243930061,1,I,20240913,20240927,20241003,20241003,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2024APC119543,VIIV,,,,,,Y,,,20241003,,HP,CN,CN,EFAVIRENZ,Renal injury,243930061,OT,,,243930061,1,20171105,20240913,2504,DAY,243930061,1,HIV infection
24395229,243952291,1,I,,20240927,20241004,20241004,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2024-156508,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20241004,,CN,CA,CA,EFAVIRENZ,Death,243952291,DE,,,,,,,,,243952291,1,Product used for unknown indication
24399288,243992881,1,I,,20240919,20241004,20241004,EXP,,CA-ASTRAZENECA-202409CAN004382CA,ALEXION PHARMACEUTICALS,,54,YR,A,,Y,,,20241004,,,CA,CA,SUSTIVA,Depression;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose,243992881,OT,,,,,,,,,243992881,1,Bipolar disorder
24401120,244011201,1,I,,20240919,20241006,20241006,EXP,,CA-ASTRAZENECA-202409CAN004848CA,ALEXION PHARMACEUTICALS,,54,YR,A,,Y,,,20241006,,,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,244011201,HO,,,,,,,,,244011201,1,Depression
24402892,244028922,2,F,,20240919,20241007,20241007,EXP,,CA-ASTRAZENECA-202409CAN004352CA,ALEXION PHARMACEUTICALS,,54,YR,A,,Y,,,20241007,,,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities;Paranoia;Prescribed overdose;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,244028922,DE,,,,,,,,,244028922,1,Depression
24403088,244030881,1,I,,20240927,20241007,20241007,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2024-154522,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20241007,,HP,CA,CA,SUSTIVA,Death,244030881,OT,,,,,,,,,244030881,1,Product used for unknown indication
24404331,244043311,1,I,,20240927,20241007,20241007,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2024-153809,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20241007,,CN,CA,CA,SUSTIVA,Death,244043311,DE,,,,,,,,,244043311,1,Product used for unknown indication
24409157,244091571,1,I,,20240927,20241008,20241008,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2024-153764,BRISTOL MYERS SQUIBB,,,,,M,Y,,,20241008,,HP,CA,CA,SUSTIVA,Death,244091571,DE,,,,,,,,,244091571,1,Product used for unknown indication
24411821,244118211,1,I,,20241007,20241008,20241008,EXP,,CA-SANDOZ INC.-SDZ2024CA085465,SANDOZ,,,,,M,Y,,,20241008,,CN,CA,CA,EFAVIRENZ,Depression;Drug interaction,244118211,DE,,,,,,,,,244118211,1,Product used for unknown indication
24414363,244143631,1,I,,20240927,20241009,20241009,EXP,CA-MHPD-001095454,CA-Accord-449512,ACCORD,,,,,M,Y,,,20241009,,CN,CA,CA,SUSTIVA,Depression;Drug interaction,244143631,DE,,,,,,,,,244143631,1,Product used for unknown indication
24424520,244245202,2,F,,20241018,20241010,20241028,EXP,,SA-TEVA-VS-3250931,TEVA,"Almangour TA, Skersick PT, Corbett A, Rodgers JE, Chang PP, Farel CE. Heart transplantation and human immunodeficiency virus-navigating drug-drug interactions: a case report. AIDS-Res-Ther 2023; 20 (1):.; Almangour TA, Skersick PT, Corbett A, Rodgers JE, Chang PP, Farel CE. Heart transplantation and human immunodeficiency virus-navigating drug-drug interactions: a case report. AIDS-Res-Ther 2023; 20 (1):.",,,A,M,Y,,,20241028,,HP,SA,SA,EFAVIRENZ,Basal cell carcinoma;Drug ineffective;Drug interaction;Drug intolerance;Neuropathy peripheral;Prostate cancer;Rash;Renal impairment;Transplant rejection,244245202,HO,,,244245202,2,2015,,,,244245202,1,Hormone replacement therapy
24431176,244311762,2,F,,20241109,20241014,20241115,EXP,,CA-CHEPLA-2022000107,CHEPLAPHARM,"Harris M, Larsen G, Montaner JS. Exacerbation of depression associated with starting raltegravir: a report of four cases. AIDS. 2008;22(14):1890-1892. doi:10.1097/QAD.0b013e32830e0169",54,YR,,M,Y,,,20241115,,HP,COUNTRY NOT SPECIFIED,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Paranoia;Prescribed overdose;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,244311762,DE,,,244311762,7,20070620,200706,,,244311762,1,Bipolar disorder
24434425,244344251,1,I,20231024,20241008,20241014,20241014,EXP,,UA-MYLANLABS-2024M1092250,MYLAN,,67,YR,,M,Y,,,20241014,,HP,UA,UA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Nephropathy toxic,244344251,OT,,,244344251,1,20190604,20240903,63,MON,244344251,1,HIV infection
24435651,244356511,1,I,,20240930,20241015,20241015,EXP,,SA-ABBVIE-5961219,ABBVIE,"Almangour TA, Skersick PT, Corbett A, Rodgers JE, Chang PP, Farel CE. Heart transplantation and human immunodeficiency virus-navigating drug-drug interactions: a case report. AIDS Res Ther. 2023;20(1):55.",,,A,M,Y,,,20241015,,HP,SA,SA,EFAVIRENZ,Basal cell carcinoma;Drug ineffective;Drug interaction;Drug intolerance;Neuropathy peripheral;Prostate cancer;Rash;Renal impairment;Transplant rejection,244356511,HO,,,244356511,3,2015,,,,244356511,1,Hormone replacement therapy
24440369,244403691,1,I,,20241007,20241016,20241016,EXP,,ZA-STRIDES ARCOLAB LIMITED-2024SP013237,STRIDES,"Chimbetete T, Choshi P, Pedretti S, Porter M, Roberts R, Lehloenya R, et al.. Skin infiltrating T-cell profile of drug reaction with eosinophilia and systemic symptoms (DRESS) reactions among HIV-infected patients.. Front-Med. 2023;10",35,YR,,M,Y,,,20241016,,HP,ZA,ZA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Drug reaction with eosinophilia and systemic symptoms,244403691,HO,,,,,,,,,244403691,1,HIV infection
24446663,244466631,1,I,20190117,20241008,20241016,20241016,EXP,,RU-GSK-RU2024EME125831,GLAXOSMITHKLINE,,,,,,Y,,,20241016,,HP,RU,RU,EFAVIRENZ,Acrochordon;Aortic arteriosclerosis;Aortic valve sclerosis;Arthralgia;Arthritis;Asthenia;Balanoposthitis;Blood HIV RNA increased;Bone lesion;Burning sensation;Candida infection;Carotid arteriosclerosis;Condition aggravated;Diarrhoea;Disease recurrence;Drug ineffective;Drug interaction;Drug intolerance;Dry mouth;Dysuria;Electrocardiogram repolarisation abnormality;Exostosis;Foot deformity;General physical health deterioration;HIV infection;Hepatic steatosis;Hepatitis C;Hepatitis toxic;Hepatomegaly;Hyperaemia;Hypertension;Immunosuppression;Infection reactivation;Lymphadenopathy;Mitral valve sclerosis;Oral candidiasis;Oropharyngeal plaque;Osteochondrosis;Pancreatic disorder;Pathogen resistance;Penile plaque;Penile swelling;Psoriasis;Psoriatic arthropathy;Respiratory tract infection;Retinopathy hypertensive;Skin papilloma;Synovitis;Vertebrobasilar insufficiency;Viral mutation identified;Weight decreased,244466631,OT,,,244466631,1,2012,20200205,411,DAY,244466631,1,HIV infection
24446664,244466641,1,I,20190117,20241008,20241016,20241016,EXP,,RU-VIIV HEALTHCARE-RU2024EME125831,VIIV,,,,,,Y,,,20241016,,HP,RU,RU,EFAVIRENZ,Acrochordon;Aortic arteriosclerosis;Aortic valve sclerosis;Arthralgia;Arthritis;Asthenia;Balanoposthitis;Blood HIV RNA increased;Bone lesion;Burning sensation;Candida infection;Carotid arteriosclerosis;Condition aggravated;Diarrhoea;Disease recurrence;Drug ineffective;Drug interaction;Drug intolerance;Dry mouth;Dysuria;Electrocardiogram repolarisation abnormality;Exostosis;Foot deformity;General physical health deterioration;HIV infection;Hepatic steatosis;Hepatitis C;Hepatitis toxic;Hepatomegaly;Hyperaemia;Hypertension;Immunosuppression;Infection reactivation;Lymphadenopathy;Mitral valve sclerosis;Oral candidiasis;Oropharyngeal plaque;Osteochondrosis;Pancreatic disorder;Pathogen resistance;Penile plaque;Penile swelling;Psoriasis;Psoriatic arthropathy;Respiratory tract infection;Retinopathy hypertensive;Skin papilloma;Synovitis;Vertebrobasilar insufficiency;Viral mutation identified;Weight decreased,244466641,OT,,,244466641,1,2012,20200205,411,DAY,244466641,1,HIV infection
24463015,244630151,1,I,,20241007,20241018,20241018,EXP,,ZA-MYLANLABS-2024M1092687,MYLAN,"Chimbetete T, Choshi P, Pedretti S, Porter M, Roberts R, Lehloenya R, et al. Skin infiltrating T-cell profile of drug reaction with eosinophilia and systemic symptoms (DRESS) reactions among HIV-infected patients. Front-Med 2023; 10.",35,YR,,M,Y,,,20241018,,HP,ZA,ZA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Drug reaction with eosinophilia and systemic symptoms,244630151,LT,,,,,,,,,244630151,1,HIV infection
24534910,245349101,1,I,,20240722,20241022,20241022,PER,,US-STRIDES ARCOLAB LIMITED-2024SP009289,STRIDES,"Woods HB, Bharathidasan K, Yang M, Nichols J, Nugent K.. Delayed onset graves disease following initiation of antiretroviral therapy in patients with human immunodeficiency virus: a case series. Am-J-Med-Sci. 2024;367 (Suppl. 1):S9-S10",51,YR,,F,Y,,,20241022,,HP,US,US,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Endocrine ophthalmopathy;Graves' disease,245349101,HO,,,,,,,,,245349101,1,HIV infection
24567979,245679791,1,I,,20190610,20241031,20241031,EXP,,GB-SANDOZ INC.-PHHY2018GB161759,SANDOZ,,,,,,Y,,,20241031,,HP,GB,GB,EFAVIRENZ,Congenital toxoplasmosis;Foetal exposure during pregnancy,245679791,CA,,,,,,,,,245679791,1,HIV infection
24573261,245732612,2,F,20240928,20241026,20241101,20241108,EXP,,CN-VIIV HEALTHCARE-CN2024APC133330,VIIV,,,,,,Y,,,20241108,,HP,CN,CN,EFAVIRENZ,Anaemia;Chills;Dyspnoea;Full blood count decreased;Myelosuppression,245732612,OT,,,245732612,1,20220101,20240928,1001,DAY,245732612,1,Acquired immunodeficiency syndrome
24603736,246037361,1,I,20240301,20241110,20241110,20241110,DIR,726795,,FDA-CTU,,52,YR,,M,N,110,KG,20241110,N,CN,GB,,EFAVIRENZ,Angina pectoris;Aspartate aminotransferase increased;Gamma-glutamyltransferase increased;Rash,246037361,OT,246037361,CSM,246037361,1,,,10,WK,246037361,1,HIV infection
24606827,246068271,1,I,,20241031,20241112,20241112,EXP,,ID-HETERO-HET2024ID04081,HETERO,,,,,M,Y,,,20241112,,PH,ID,ID,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Asthenia;Lung disorder;Nausea;Vomiting,246068271,HO,,,246068271,1,20241015,,,,246068271,1,HIV infection
24617911,246179111,1,I,,20241106,20241114,20241114,EXP,,ZA-ASTRAZENECA-202411SSA003894ZA,ALEXION PHARMACEUTICALS,,60,YR,A,,Y,,,20241114,,,ZA,ZA,Cipla efavirenz,Infection;Pneumothorax;Spinal artery thrombosis,246179111,OT,,,,,,,,,246179111,1,Diabetes mellitus
24622957,246229571,1,I,20241010,20241025,20241115,20241115,EXP,CN-NMPACDR-3101161058516202400214,CN-BAXTER-2024BAX026892,BAXTER,,58,YR,,F,Y,50,KG,20241115,,MD,CN,CN,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Asthenia;Diarrhoea;Full blood count decreased;Hypokalaemia;Urinary tract infection;Vomiting,246229571,OT,,,246229571,1,20241003,20241003,1,DAY,246229571,1,Lymphoma
24625982,246259821,1,I,,20241108,20241115,20241115,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-2024-176909,BRISTOL-MYERS SQUIBB COMPANY,"Laurenda O, Anneka P, Giovanni V, Adele M, Max W, Yvonne G, et al. Autoimmune hepatitis in people living with HIV: a case series and review of literature. The Open AIDS Journal. 2023;17:1-7. doi:10.2174/18746136-v17-230825-2023-15.",47,YR,A,F,Y,,,20241115,,HP,GB,GB,EFAVIRENZ,Drug-induced liver injury,246259821,OT,,,246259821,1,201001,,,,246259821,1,HIV infection
24627476,246274762,2,F,20110101,20241120,20241116,20241129,EXP,,GB-MACLEODS PHARMA-MAC2024050246,MACLEODS,,,,,,Y,,,20241129,,HP,GB,GB,EFAVIRENZ,Autoimmune hepatitis;Portal fibrosis,246274762,OT,,,246274762,1,201001,201101,,,246274762,1,HIV infection
24652091,246520911,1,I,20241120,20241121,20241121,20241121,DIR,FDA-CDER-CTU-2024-80625,,FDA-CTU,,64,YR,,M,N,,,20241121,N,PH,US,,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Death,246520911,DE,246520911,HP,246520911,1,20240406,20241120,,,246520911,1,HIV infection
24652593,246525932,2,F,,20241213,20241122,20241218,EXP,,CA-MYLANLABS-2024M1104196,MYLAN,,54,YR,,M,Y,,,20241218,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities;Off label use,246525932,OT,,,,,,,,,246525932,1,Bipolar disorder
24677029,246770291,1,I,,20241122,20241129,20241129,EXP,,ZA-ASTRAZENECA-202411SSA018210ZA,ALEXION PHARMACEUTICALS,,46,YR,A,,Y,,,20241129,,,ZA,ZA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR\TENOFOVIR DISOPROXIL FUMARATE,Immobile,246770291,OT,,,,,,,,,246770291,1,Diabetes mellitus
24677350,246773501,1,I,,20241121,20241129,20241129,EXP,,JP-GSK-JP2024JPN146263,GLAXOSMITHKLINE,Yoshida K. EACS LIVE! - Interactive case-based discussion -. The 38th Annual Meeting of the Japanese for AIDS Research,,,,,Y,,,20241129,,MD,JP,JP,EFAVIRENZ,Abscess limb;Ascites;CD4 lymphocytes abnormal;Cytomegalovirus colitis;Cytomegalovirus oesophagitis;Cytomegalovirus pancreatitis;Depression;Disseminated mycobacterium avium complex infection;Heart failure with reduced ejection fraction;Ileus paralytic;Immune reconstitution inflammatory syndrome;Liver abscess;Muscular weakness;Pneumocystis jirovecii pneumonia;Staphylococcal infection;Therapy interrupted,246773501,HO,,,,,,,,,246773501,1,HIV infection
24677351,246773511,1,I,,20241121,20241129,20241129,EXP,,JP-VIIV HEALTHCARE-JP2024JPN146263,VIIV,Yoshida K. EACS LIVE! - Interactive case-based discussion -. The 38th Annual Meeting of the Japanese for AIDS Research,,,,,Y,,,20241129,,MD,JP,JP,EFAVIRENZ,Abscess limb;Ascites;CD4 lymphocytes abnormal;Cytomegalovirus colitis;Cytomegalovirus oesophagitis;Cytomegalovirus pancreatitis;Depression;Disseminated mycobacterium avium complex infection;Heart failure with reduced ejection fraction;Ileus paralytic;Immune reconstitution inflammatory syndrome;Liver abscess;Muscular weakness;Pneumocystis jirovecii pneumonia;Staphylococcal infection;Therapy interrupted,246773511,HO,,,,,,,,,246773511,1,HIV infection
24681754,246817541,1,I,20241111,20241120,20241130,20241130,EXP,,RU-AMAROX PHARMA-HET2024RU04375,HETERO,,,,,M,Y,75,KG,20241130,,CN,RU,RU,EFAVIRENZ,Rash pruritic,246817541,OT,,,246817541,1,20241103,20241111,9,DAY,246817541,1,HIV infection
24684357,246843571,1,I,20240205,20241202,20241202,20241202,EXP,FR-AFSSAPS-NT2024001436,"FR-B.I. Pharmaceuticals,Inc./Ridgefield-2024-BI-066009",BOEHRINGER INGELHEIM,,61,YR,A,F,Y,,,20241202,,MD,FR,FR,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL MALEATE,Osteoporosis,246843571,OT,,,246843571,1,20090824,20240205,5278,DAY,246843571,1,HIV infection
24695424,246954241,1,I,20240205,20241203,20241204,20241204,EXP,FR-AFSSAPS-NT2024001436,FR-GILEAD-2024-0695837,GILEAD,,61,YR,A,F,Y,,,20241204,,MD,FR,FR,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL MALEATE,Osteoporosis,246954241,OT,,,246954241,1,20090824,20240205,5278,DAY,246954241,1,HIV infection
24699442,246994421,1,I,,20241130,20241205,20241205,EXP,,JP-VIIV HEALTHCARE-JP2024JPN150630,VIIV,,,,,,Y,,,20241205,,MD,JP,JP,EFAVIRENZ,Lymphoma,246994421,DE,,,,,,,,,246994421,5,Kaposi's sarcoma
24700032,247000321,1,I,20241113,20241203,20241205,20241205,EXP,FR-AFSSAPS-PA2024001835,FR-GILEAD-2024-0695833,GILEAD,,,,A,M,Y,,,20241205,,CN,FR,FR,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Delirium;Hemiparesis;Wrong drug,247000321,HO,,,247000321,1,20241113,20241116,3,DAY,247000321,1,Prophylaxis against HIV infection
24700289,247002891,1,I,,20240124,20241205,20241205,EXP,,GR-ALKEM LABORATORIES LIMITED-GR-ALKEM-2024-01044,ALKEM,"Aperis G, Paliouras C, Zervos A, Arvanitis A, Alivanis P. Lactic acidosis after concomitant treatment with metformin and tenofovir in a patient with HIV infection. Journal of Renal Care. 2011;37(1):25-29",74,YR,,M,Y,,,20241205,,MD,GR,GR,EFAVIRENZ,Lactic acidosis,247002891,HO,,,,,,,,,247002891,1,Type 2 diabetes mellitus
24714767,247147671,1,I,20190101,20241202,20241210,20241210,EXP,,RO-VIIV HEALTHCARE-RO2024EME151507,VIIV,,,,,,Y,,,20241210,,MD,RO,RO,EFAVIRENZ,Dyslipidaemia;Gallbladder cholesterolosis;Goitre;Hepatic steatosis;Obesity;Premature menopause,247147671,OT,,,247147671,1,20040101,,,,247147671,1,HIV infection
24718305,247183051,1,I,20101001,20241202,20241210,20241210,EXP,,RO-GSK-RO2024EME151506,GLAXOSMITHKLINE,,,,,,Y,,,20241210,,MD,RO,RO,EFAVIRENZ,Anaemia;Depression;Dyslipidaemia;Hepatitis toxic;Hyperglycaemia;Hypertension;Intervertebral disc degeneration;Myocardial ischaemia;Overweight,247183051,OT,,,247183051,1,20100911,20211010,4047,DAY,247183051,1,HIV infection
24718306,247183061,1,I,20101001,20241202,20241210,20241210,EXP,,RO-VIIV HEALTHCARE-RO2024EME151506,VIIV,,,,,,Y,,,20241210,,MD,RO,RO,EFAVIRENZ,Anaemia;Depression;Dyslipidaemia;Hepatitis toxic;Hyperglycaemia;Hypertension;Intervertebral disc degeneration;Myocardial ischaemia;Overweight,247183061,OT,,,247183061,1,20100911,20211010,4047,DAY,247183061,1,HIV infection
24719750,247197501,1,I,20240205,20241129,20241211,20241211,EXP,,FR-CIPLA LTD.-2024FR14393,CIPLA,,,,,,Y,,,20241211,,MD,FR,FR,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL MALEATE,Osteoporosis,247197501,OT,,,247197501,1,20090824,20240205,5278,DAY,247197501,1,HIV infection
24719888,247198881,1,I,20241113,20241129,20241211,20241211,EXP,,FR-CIPLA LTD.-2024FR14646,CIPLA,,,,,,Y,,,20241211,,CN,FR,FR,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Delirium;Hemiparesis;Wrong drug,247198881,HO,,,247198881,2,20241113,20241116,3,DAY,247198881,1,Prophylaxis against HIV infection
24722325,247223251,1,I,20240205,20241205,20241211,20241211,EXP,FR-AFSSAPS-NT2024001436,FR-MYLANLABS-2024M1110553,MYLAN,,61,YR,,F,Y,,,20241211,,MD,FR,FR,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Osteoporosis,247223251,OT,,,247223251,1,20200302,20240205,1436,DAY,247223251,1,HIV infection
24722334,247223341,1,I,20241113,20241205,20241211,20241211,EXP,FR-AFSSAPS-PA2024001835,FR-MYLANLABS-2024M1110506,MYLAN,,,,A,M,Y,,,20241211,,CN,FR,FR,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL SUCCINATE,Delirium;Hemiparesis;Wrong drug,247223341,HO,,,247223341,2,20241113,20241116,4,DAY,247223341,1,Prophylaxis against HIV infection
24724291,247242911,1,I,,20241204,20241212,20241212,EXP,,CO-STRIDES ARCOLAB LIMITED-2024SP016429,STRIDES,"Grajales-Urrego DM, Mantilla-Sylvain F, Rolon-Cadena MC, Basto-Borbon WM, Alvarez-Figueroa J.. Venous intestinal ischemia of fungal origin as a cause of intestinal obstruction in immunocompromised patients: case report and literature review.. Gut-Path. 2024;16 (1)",48,YR,,M,Y,,,20241212,,HP,CO,CO,EFAVIRENZ,Acute myeloid leukaemia;Gastrointestinal mucormycosis;Intestinal obstruction,247242911,HO,,,,,,,,,247242911,1,HIV infection
24724303,247243031,1,I,,20241203,20241212,20241212,EXP,,BR-STRIDES ARCOLAB LIMITED-2024SP016364,STRIDES,"Mari JF, Kruschewsky WLL, Guimaraes LSP, Avancini J, Trindade MAB, Nastri ACDSS.. HIV COINFECTION AND LEPROSY: TWO CASE REPORTS WITH LEPROSY VIRCHOWIAN AND ERYTHEMA NODOSUM NECROTIZING .. Brazil-J-Infect-Dis. 2023;27 (Suppl. 1)",36,YR,,F,Y,,,20241212,,HP,BR,BR,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Erythema nodosum;Type 2 lepra reaction,247243031,OT,,,247243031,2,,,6,MON,247243031,1,Leprosy
24726181,247261811,1,I,,20241204,20241212,20241212,EXP,,CO-MYLANLABS-2024M1111101,MYLAN,"Grajales-Urrego DM, Mantilla-Sylvain F, Rolon-Cadena MC, Basto-Borbon WM, Alvarez-Figueroa J. Venous intestinal ischemia of fungal origin as a cause of intestinal obstruction in immunocompromised patients: case report and literature review. Gut-Path 2024; 16 (1):.",48,YR,,M,Y,,,20241212,,HP,CO,CO,EFAVIRENZ,Acute myeloid leukaemia;Gastrointestinal mucormycosis;Intestinal obstruction,247261811,DE,,,,,,,,,247261811,1,HIV infection
24746487,247464871,1,I,,20241210,20241218,20241218,EXP,,IE-GALDERMA-IE17005567,GALDERMA,"Broderick C, Quinlan C, Gulmann C, O^Kane M. Recalcitrant cutaneous sarcoidosis, with response to daylight photodynamic therapy. Autumn Meeting of the Irish Association of Dermatologists. 2016",,,,,Y,,,20241218,,HP,IE,IE,EFAVIRENZ,Cushingoid;Intentional product use issue;Leukopenia;Skin atrophy,247464871,OT,,,,,,,,,247464871,1,Cutaneous sarcoidosis
24747780,247477801,1,I,,20241213,20241218,20241218,EXP,,IE-SANDOZ INC.-PHHY2018IE041144,SANDOZ,,37,YR,,F,Y,,,20241218,,HP,IE,IE,EFAVIRENZ,Cushingoid;Drug ineffective;Drug ineffective for unapproved indication;Leukopenia;Off label use;Product use in unapproved indication;Skin atrophy,247477801,OT,,,,,,,,,247477801,1,Sarcoidosis
24750479,247504792,2,F,,20241218,20241218,20241224,EXP,,CN-GILEAD-2024-0696989,GILEAD,"Niya H, Caiqiong Z, Zhiqing Z. Tenofovir disoproxil fumarate induced Fanconi syndrome with renal diabetes insipidus a case report. Chin J Hosp Pharm. 2024;44(22):2670-2672. doi:10.13286/j.1001-5213.2024.22.18",44,YR,A,M,Y,58,KG,20241224,,HP,CN,CN,EFAVIRENZ,Azotaemia;Fanconi syndrome acquired,247504792,OT,,,,,,,,,247504792,1,HIV infection
24752300,247523001,1,I,20241121,20241128,20241219,20241219,EXP,,CN-JNJFOC-20241242349,JOHNSON AND JOHNSON,,43,YR,A,M,Y,66,KG,20241219,,HP,CN,CN,EFAVIRENZ,Alanine aminotransferase increased;Aspartate aminotransferase increased;Blood alkaline phosphatase increased;Blood bilirubin increased;Gamma-glutamyltransferase increased,247523001,HO,,,247523001,1,20240903,20241126,84,DAY,247523001,1,HIV infection
24767098,247670981,1,I,,20241216,20241223,20241223,EXP,,US-TEVA-VS-3277127,TEVA,"Kowalczyk M, Rubinstein PG, Aboulafia DM. Initial Experience with Thrombopoetin Receptor Agonists (TRA) in 5 Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura (ITP). Blood 2014; 124 (21): 5014.",,,A,,Y,,,20241223,,HP,US,US,EFAVIRENZ\EMTRICITABINE\TENOFOVIR\TENOFOVIR DISOPROXIL FUMARATE,Treatment failure,247670981,DE,,,,,,,,,247670981,1,Immune thrombocytopenia
24785021,247850211,1,I,,20241219,20241228,20241228,EXP,,ES-AMGEN-ESPSP2024251255,AMGEN,Castells L.; Esteban J.I.; Bilbao I. et al.. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients. Antiviral therapy. 2006;11 (8):1061-1070,38,YR,A,M,Y,,,20241228,,HP,ES,ES,EFAVIRENZ,Anaemia;Depression;Hepatitis chronic active;Hypertension;Influenza like illness;Lipodystrophy acquired;Liver transplant rejection;Obesity;Pneumonia bacterial,247850211,OT,,,,,,,,,247850211,1,Haemoglobin decreased
24785494,247854941,1,I,,20241219,20241228,20241228,EXP,,ZA-ASTRAZENECA-202412SSA016053ZA,ALEXION PHARMACEUTICALS,,38,YR,A,,Y,,,20241228,,,ZA,ZA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR\TENOFOVIR DISOPROXIL FUMARATE,Arthralgia,247854941,HO,,,,,,,,,247854941,1,Asthma
24788646,247886461,1,I,,20241216,20241230,20241230,EXP,,CO-AUROBINDO-AUR-APL-2024-062898,AUROBINDO,"Grajales-Urrego DM, Mantilla-Sylvain F, Rolon-Cadena MC, Basto-Borbon WM, Alvarez-Figueroa J.. Venous intestinal ischemia of fungal origin as a cause of intestinal obstruction in immunocompromised patients: case report and literature review. Gut Pathogens. 2024;16:66",48,YR,,M,Y,,,20241230,,HP,CO,CO,EFAVIRENZ,Acute myeloid leukaemia;Gastrointestinal mucormycosis,247886461,HO,,,,,,,,,247886461,1,HIV infection
6870591,68705917,7,F,,20240927,20081231,20241010,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-14455729,BRISTOL MYERS SQUIBB,"Harris M, Larsen G, Montaner JS. Exacerbation of depression associated with starting raltegravir: a report of four cases. AIDS. 2008;22(14):1890-2. doi:10.1097/QAD.0b013e32830e0169.",54,YR,A,M,Y,,,20241011,,MD,CA,CA,EFAVIRENZ;SUSTIVA,Anxiety;Depression;Depression suicidal;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities;Off label use;Paranoia;Prescribed overdose;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,68705917,DE,,,68705917,9,2004,,4,YR,68705917,1,Bipolar disorder
7117171,711717119,19,F,,20241115,20090917,20241129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-14780902,BRISTOL-MYERS SQUIBB COMPANY,"Pfeffer G, Cote HCF, Montaner JS, Li CC, Jitratkosol M, Mezei MM. Ophthalmoplegia and ptosis: mitochondrial toxicity in patients receiving HIV therapy. Neurology. 2009 Jul 07;73(1):71-2.doi:10.1212/WNL.0b013e3181aae814.",52,YR,A,M,Y,,,20241129,,MD,CA,CA,EFAVIRENZ;SUSTIVA,Blood lactic acid increased;Diplopia;Dysphagia;Eyelid ptosis;Lipodystrophy acquired;Mitochondrial toxicity;Ophthalmoplegia,711717119,OT,,,711717119,1,200802,,1189,DAY,711717119,1,HIV infection
